{
    "2021-09-14": [
        [
            {
                "time": "",
                "original_text": "万泰生物：公司传统的冻干水痘减毒活疫苗处于III临床试验中，新型冻干水痘减毒活疫苗（VZV-7D）处于II期临床试验中",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "冻干水痘减毒活疫苗",
                        "III临床试验",
                        "新型疫苗",
                        "VZV-7D",
                        "II期临床试验"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗研发"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：公司的20价肺炎多糖蛋白结合疫苗主要面向2岁及以下婴幼儿",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "20价肺炎多糖蛋白结合疫苗",
                        "婴幼儿市场"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗研发"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}